Historical stock lookup

Adjusted historic prices for the week of August 14, 2017
Date Open High Low Close Volume
Aug 14, 2017 115.04 115.94 114.96 115.64 1,295,686
Aug 15, 2017 115.78 115.78 114.69 114.83 898,391
Aug 16, 2017 115.22 115.93 115.00 115.57 943,562
Aug 17, 2017 115.49 115.79 113.36 113.57 980,870
Aug 18, 2017 113.37 113.61 112.34 113.11 1,134,626

Year End Stock Prices

Year end EW stock price

The historical stock information provided is for informational purposes only and is not intended for trading purposes. The historical stock information is provided by Mergent, a third party service, and Edwards Lifesciences Corporation does not maintain or provide information directly to this service. Prices display split-adjusted cost basis per share on that date.

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Actual Price is not adjusted for splits or dividends. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above.

The closing price above is not necessarily indicative of future price performance.

Effective May 28, 2010, Edwards Lifesciences' stock split on a two-for-one basis.

News & events
Corporate governance
Financial information
Stock info & tools

Contacts

General investor relations

investor_relations@edwards.com
phone: (949) 250-2806
fax: (949) 250-2248

Investor relations team

David K. Erickson
Vice President, Investor Relations
phone: (949) 250-6826

 

Tammy Perry
Sr. Manager, Investor Relations
phone: (949) 250-2752

 
Mike Feher
Manager, Investor Relations
phone: (949) 250-2403
Proxy and stock certificate questions

Computershare Shareholder Services
P.O. Box 43010
Providence, RI 02940
www.computershare.com
phone: (800) 446-2617


Stock transfer agent
Information request

Submit questions for the Investor Relations Department.
Submit

Email alerts subscription

Get news delivered straight to your inbox.
Subscribe